SpaceX IPO at 94x Sales? Here's Why I'm Sitting This One Out

SpaceX IPO at 94x Sales? Here's Why I'm Sitting This One Out

SpaceX IPO at 94x Sales? Here's Why I'm Sitting This One Out

·2 min read
Share

Straight to it: I'm not buying this IPO

SpaceX is going public on June 12 at roughly $135 per share, aiming for a $1.75 to $2 trillion market cap right out of the gate. It launches rockets, it's led by Elon Musk, and it comes wrapped in a Mars story. And I'm still stepping back from it.

My reasoning isn't emotional. It comes down to one line of math.

The core: what a 94x price-to-sales ratio is telling you

The first number I look at on any valuation is the price-to-sales ratio — how much the market is paying for every dollar of revenue a company actually brings in.

SpaceX has about $18 billion in revenue. Set the target market cap at $1.75-$2 trillion and the ratio lands around 94x.

Here's the frame I use:

CategoryP/S ratio
HealthyUnder 2x
ExpensiveAbove 4x
SpaceX target~94x

If I call anything over 4x expensive, then 94x is in another universe. It means a flawless future is already priced in. Starlink scaling explosively, the Mars business becoming real, launch costs falling for years — all of it baked into the price before day one.

What it means: a great company isn't a great investment

I'm not saying SpaceX is a bad company. It might be one of the most impressive companies of our era. But a great company and a great entry price are two completely different things.

On IPO day — especially for a hyped name — retail investors often end up holding the most expensive shares. Institutions and early backers got in far lower, and the launch-day excitement becomes the stage where they take profits.

That's why, instead of buying the stock directly, I lean toward indirect exposure through ETFs that give me a measured slice of names like this while diversification keeps the risk in check.

The risk and the counterargument

There's a fair pushback: "P/S doesn't matter for some companies." Amazon looked expensive on every traditional metric early on and still beat the market.

True. But that's survivorship — the rare names that made it. To bet on 94x, nearly everything has to go perfectly. I don't have enough conviction to put my capital behind those odds. I'll watch until the price comes back to something rational, or until revenue grows into the valuation.

Investing isn't a game of finding great companies. It's a game of buying great companies at good prices.

Share

Ecconomi

Finance & Economics major at a U.S. university. Securities report analyst.

Learn more
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Investment decisions should be made at your own discretion and risk.

More in this Category

Previous Posts

Ecconomi

A professional financial content platform providing in-depth analysis and investment insights on global financial markets.

Navigation

The content on this site is for informational purposes only and should not be construed as investment advice or financial guidance. Investment decisions should be made based on your own judgment and responsibility.

© 2026 Ecconomi. All rights reserved.